JNCE

Jounce Therapeutics, Inc. Common Stock
JNCE

Overview Fund Trends Analyst Outlook Journalist POV
Delisted

JNCE was delisted on the 3rd of May, 2023.

Back to rankings
Buy
Hold
Sell

We haven’t received any recent analyst ratings for JNCE.

We couldn't find any ratings matching your filter criteria.